CHEMED CORP 10-Q Summary: Quarter Ended June 30, 2002
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended June 30, 2002, and the six-month period ended June 30, 2002, for Chemed Corporation. The Company operates primarily through three segments: Roto-Rooter (plumbing and drain cleaning), Patient Care (home health care), and Service America (HVAC and facility services). As of July 31, 2002, there were 9,795,700 shares of common stock outstanding.
Key Financial Metrics
| Metric | Q2 2002 | Q2 2001 | 6M 2002 | 6M 2001 |
|---|---|---|---|---|
| Service Revenues & Sales | $116.6M | $120.8M | $233.6M | $242.0M |
| Net Income | $4.6M | $1.5M | $9.2M | $6.0M |
| Diluted EPS | $0.46 | $0.16 | $0.93 | $0.60 |
| Operating Income | $7.6M | $6.3M | $13.3M | $13.9M |
| Operating Margin | 6.5% | 5.2% | 5.7% | 5.7% |
| Net Cash from Operations | N/A | N/A | $17.8M | $17.5M |
| Cash & Equivalents | $11.5M | $12.6M | $11.5M | $12.6M |
| Total Debt (Current + Long-term) | $56.2M | $56.4M | $56.2M | $56.4M |
Note: Q2 cash flow data is not explicitly broken out in the source text; 6M figures are provided.
Material Changes vs. Prior Period
- Revenue Decline: Total revenues decreased 3% in Q2 and 3% in the first six months of 2002 compared to 2001. The Roto-Rooter segment saw a 6% decline in Q2 revenues, while Service America declined 10% due to lower contract renewals and retail sales. Patient Care revenues increased 5% in Q2.
- Profitability Improvement: Net income increased significantly (212% in Q2, 55% in 6M) primarily due to the elimination of goodwill amortization charges under new accounting standards (SFAS No. 142) effective Jan 1, 2002. In 2001, goodwill amortization reduced net income by $1.2M in Q2 and $2.5M in the first six months.
- Interest Expense Reduction: Interest expense dropped 48% in Q2 and 48% in the first six months of 2002, attributed to debt refinancing at lower rates in late 2001 and reduced debt levels.
- EBITDA Decline: Despite higher net income, EBITDA declined slightly in Q2 (2%) and significantly in the first six months (11%) compared to 2001, driven by lower operating profits in the Roto-Rooter segment.
Outlook, Risks, and Contingencies
- Pending Sale of Patient Care: On May 8, 2002, Chemed announced an agreement to sell its Patient Care subsidiary for approximately $70 million in gross cash. The transaction is expected to close before year-end 2002, contingent on regulatory approvals and financing commitments by September 1, 2002. Management expects to recognize an after-tax loss of approximately $1 million on the sale.
- Liquidity: The Company maintains approximately $27.7 million in unused lines of credit. Management considers liquidity satisfactory for foreseeable needs.
- Legal Contingencies: The Company is involved in a class action lawsuit regarding unlicensed employees in the Roto-Rooter segment. Management contests the allegations and believes them baseless; no material liability is currently estimated.
- Accounting Changes: The adoption of SFAS No. 142 eliminated goodwill amortization, significantly altering year-over-year earnings comparisons. Goodwill impairment testing was completed as of June 30, 2002, with no impairment identified.
Investor Verification Checklist
- Verify the closing status and final terms of the Patient Care subsidiary sale, including the expected $1 million after-tax loss.
- Confirm the impact of the elimination of goodwill amortization on future earnings stability versus historical adjusted earnings.
- Monitor the Roto-Rooter segment's revenue trends, specifically the 6% decline in Q2, to assess if this is a temporary fluctuation or a structural shift.
- Review the status of the class action lawsuit regarding unlicensed plumbing employees for any updates on potential liability.
- Assess the Company's capital allocation strategy for the proceeds from the Patient Care sale (acquisitions vs. debt repayment).